Locsense and Micronit Microtechnologies join forces in the development of Heart-on-Chip technology for Atrial Fibrillation research. Atrial fibrillation is one of the most frequently occurring heart diseases, where the patients suffer from an irregular heartbeat. This may lead to blood clots, stroke and even heart failure.
The platform enables the development of precision medicine and treatment. The technical implementation includes a microtiter plate for cell culture with stimuli and detection. The “Recardio” project is supported by the Provincie Overijssel.
